Fuller & Thaler Asset Management, Inc. United Therapeutics Corp Transaction History

Fuller & Thaler Asset Management, Inc.

$25 Billion
Q3 2024

A detailed history of Fuller & Thaler Asset Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 568,392 shares of UTHR stock, worth $220 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

568,392

Previous 574,976 1.15%

Holding current value

$220 Million

Previous $183 Million 11.21%

% of portfolio

0.81%

Previous 0.79%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $2.05 Million - $2.39 Million	-6,584 Reduced 1.15%	568,392 $204 Million
Q2 2024 Aug 09, 2024	BUY	$228.26 - $319.04 $433,922 - $606,495	1,901 Added 0.33%	574,976 $183 Million
Q1 2024 May 13, 2024	BUY	$210.76 - $249.51 $29.9 Million - $35.4 Million	141,959 Added 32.93%	573,075 $132 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $46,414 - $55,499	216 Added 0.05%	431,116 $94.8 Million
Q3 2023 Nov 13, 2023	SELL	$211.82 - $248.24 $321,966 - $377,324	-1,520 Reduced 0.35%	430,900 $97.3 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $18.7 Million - $21.2 Million	-91,174 Reduced 17.41%	432,420 $95.5 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $974,003 - $1.26 Million	-4,573 Reduced 0.87%	523,594 $117 Million
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $4.79 Million - $6.52 Million	-23,241 Reduced 4.21%	528,167 $147 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $20.7 Million - $24.9 Million	-102,005 Reduced 15.61%	551,408 $115 Million
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $1.9 Million - $2.62 Million	-10,882 Reduced 1.64%	653,413 $154 Million
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $11.1 Million - $14.4 Million	-67,095 Reduced 9.17%	664,295 $119 Million
Q4 2021 Feb 09, 2022	BUY	$184.32 - $216.08 $5.4 Million - $6.33 Million	29,292 Added 4.17%	731,390 $158 Million
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $14 Million - $16.7 Million	77,919 Added 12.48%	702,098 $130 Million
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $2.96 Million - $3.68 Million	17,386 Added 2.87%	624,179 $112 Million
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $79.4 Million - $90.2 Million	515,942 Added 567.9%	606,793 $101 Million
Q4 2020 Feb 11, 2021	BUY	$101.87 - $151.79 $9.25 Million - $13.8 Million	90,851 New	90,851 $13.8 Million
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $9,580 - $11,006	-128 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $341 - $388	3 Added 2.4%	128 $16,000
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $13,401 - $18,992	125 New	125 $14,000

Others Institutions Holding UTHR

# of Institutions

657

Shares Held

42.8M

Call Options Held

153K

Put Options Held

278K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Account

Fuller & Thaler Asset Management, Inc. United Therapeutics Corp Transaction History